Laboratory of Experimental Surgery and Surgical Research N.S. Christeas, Athens University Medical School, National and Kapodistrian University of Athens, Athens, Greece.
, 15Β, Ag. Thoma str, 115 27, Athens, Greece.
Int Urol Nephrol. 2022 Jan;54(1):137-148. doi: 10.1007/s11255-021-02831-9. Epub 2021 Mar 14.
Acute kidney injury represents a major adverse effect of vancomycin administration. The aim of the present study is to accumulate all biopsy-proven cases of vancomycin nephrotoxicity and assess the association of histopathological features with renal prognosis.
Medline, Scopus, CENTRAL, Web of Science, and Clinicaltrials.gov were systematically searched from inception to 29 September 2020. All case reports/series providing individual data of patients with biopsy-proven vancomycin nephrotoxicity were held eligible. A time-to-event analysis was performed evaluating the effects of histological diagnosis on renal recovery.
Overall, 18 studies were included, comprising 21 patients. Acute tubulointerstitial nephritis was the predominant pattern in 9 patients and was associated with a significantly higher risk of permanent renal dysfunction (HR: 5.08, 95% CI: [1.05-24.50)] compared to acute tubular necrosis. Tubulitis and eosinophilic infiltration were the most common histopathological findings, while interstitial fibrosis was linked to significantly worse renal prognosis (HR: 5.55, 95% CI: 1.13-27.27). Immunofluorescence and electron microscopy features were non-specific. Obstruction by tubular casts composed of vancomycin aggregates and uromodulin has been identified as a new mechanism of nephrotoxicity.
Acute tubular necrosis and tubulointerstitial nephritis represent the main histological patterns of vancomycin-induced acute kidney injury. The presence of fibrosis in the context of interstitial inflammation may be linked to lower recovery rates and worse long-term renal outcomes. A novel cast nephropathy obstructive mechanism has been suggested, necessitating further confirmation. Large-scale studies should define the exact indications of kidney biopsy in cases with suspected vancomycin nephrotoxicity.
急性肾损伤是万古霉素治疗的主要不良反应。本研究旨在收集所有经活检证实的万古霉素肾毒性病例,并评估组织病理学特征与肾脏预后的关系。
从建库至 2020 年 9 月 29 日,系统地检索了 Medline、Scopus、CENTRAL、Web of Science 和 Clinicaltrials.gov。纳入所有提供经活检证实的万古霉素肾毒性患者个体数据的病例报告/系列。进行了时间事件分析,评估了组织学诊断对肾脏恢复的影响。
共纳入 18 项研究,包括 21 例患者。9 例患者表现为急性肾小管间质性肾炎,与永久性肾功能障碍的风险显著升高相关(HR:5.08,95%CI:[1.05-24.50]),与急性肾小管坏死相比。小管炎和嗜酸性粒细胞浸润是最常见的组织病理学发现,而间质纤维化与明显较差的肾脏预后相关(HR:5.55,95%CI:1.13-27.27)。免疫荧光和电子显微镜特征是非特异性的。由万古霉素聚集物和尿调素组成的管状铸型阻塞被认为是一种新的肾毒性机制。
急性肾小管坏死和肾小管间质性肾炎是万古霉素引起的急性肾损伤的主要组织学模式。间质炎症中存在纤维化可能与较低的恢复率和较差的长期肾脏结局相关。提出了一种新的铸型肾病阻塞机制,需要进一步证实。大型研究应确定在疑似万古霉素肾毒性病例中进行肾活检的确切适应证。